Racial and ethnic disparities in human papillomavirus (HPV)-associated cancer burden with first- and second-generation HPV vaccines

Documenti analoghi

• Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2013)
• Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
  di: Petrosky, Emiko, et al.
  Pubblicazione: (2015)
• Cost-effectiveness of Human Papillomavirus Vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2008)
• The Estimated Impact of Human Papillomavirus Vaccine Coverage on the Lifetime Cervical Cancer Burden Among Girls Currently Aged 12 Years and Younger in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2014)
• Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States
  di: Chesson, Harrell W., et al.
  Pubblicazione: (2019)